4-aminopyrrolopyrimidines as kinase inhibitors

Details 4-aminopyrrolopyrimidines as kinase inhibitors 4-aminopyrrolopyrimidines as kinase inhibitors

C - Chemistry, Metallurgy

07

D

C07D 487/04 (2006.01) A61K 31/505 (2006.01)

Patent

CA 2344262

Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases whose activity is inhibited by these compounds are involved in immunologic, hyperproliferative or angiogenic processes. Thus, these compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferative is a factor. These compounds can be used to treat cancer, hyperproliferation disorders, rheumatoid arthritis, disorders of the immune system, transplant rejection, and inflammatory disorders.

L'invention concerne des composés chimiques, représentés par la formule développée (I), ainsi que des sels physiologiquement acceptables de ces composés. Ces composés inhibent l'activité des sérine/thréonine kinases et des tyrosine kinases. Plusieurs de ces kinases, dont l'activité est inhibée par ces composés, jouent un rôle dans des processus immunologiques, hyperprolifératifs, ou angiogéniques. Les composés de l'invention peuvent, de ce fait, améliorer des états pathologiques, pour lesquels l'angiogenèse ou l'hyperprolifération des cellules endothéliales constituent un facteur. Ces composés peuvent être utilisés pour le traitement du cancer, des troubles hyperprolifératifs, de la polyarthrite rhumatoïde, des dysfonctionnement du système immunitaire, des rejets du greffon, et des troubles inflammatoires.

Affiliated with

Also associated with

Rating

4-aminopyrrolopyrimidines as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-aminopyrrolopyrimidines as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrrolopyrimidines as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2056068